Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 152

1.

The feasibility of expectant management with inner-city men with newly diagnosed localized prostate cancer.

Anai S, Nakamura K, Chang MN, Pendleton J, Yacoub S, Rosser CJ.

J Health Care Poor Underserved. 2008 Feb;19(1):164-70. doi: 10.1353/hpu.2008.0024.

PMID:
18263992
2.

Clarifying uncertainty regarding detection and treatment of early-stage prostate cancer.

Wilt TJ.

Semin Urol Oncol. 2002 Feb;20(1):10-7. Review.

PMID:
11828353
3.

Expectant management of veterans with early-stage prostate cancer.

Filson CP, Shelton JB, Tan HJ, Kwan L, Skolarus TA, Saigal CS, Litwin MS.

Cancer. 2016 Feb 15;122(4):626-33. doi: 10.1002/cncr.29785. Epub 2015 Nov 5.

PMID:
26540451
4.

Active surveillance of prostate cancer in African American men.

Silberstein JL, Feibus AH, Maddox MM, Abdel-Mageed AB, Moparty K, Thomas R, Sartor O.

Urology. 2014 Dec;84(6):1255-61. doi: 10.1016/j.urology.2014.06.064. Epub 2014 Oct 3. Review.

PMID:
25283702
5.

Assessment of the quality of medical care among patients with early stage prostate cancer undergoing expectant management in the United States.

Ritchey J, Gay EG, Spencer BA, Miller DC, Wallner LP, Stewart AK, Dunn RL, Litwin MS, Wei JT.

J Urol. 2012 Sep;188(3):769-74. doi: 10.1016/j.juro.2012.04.106. Epub 2012 Jul 19.

PMID:
22818140
6.
7.

Expectant management of localized prostate cancer--who, what, when, where and how?

Ehdaie B.

J Urol. 2012 Sep;188(3):696-7. doi: 10.1016/j.juro.2012.06.049. Epub 2012 Jul 19. No abstract available.

PMID:
22818346
8.

What percentage of patients with newly diagnosed carcinoma of the prostate are candidates for surveillance? An analysis of the CaPSURE database.

Barocas DA, Cowan JE, Smith JA Jr, Carroll PR; CaPSURE Investigators.

J Urol. 2008 Oct;180(4):1330-4; discussion 1334-5. doi: 10.1016/j.juro.2008.06.019. Epub 2008 Aug 15.

PMID:
18707731
9.

Further support for active surveillance in the management of low-volume, low-grade prostate cancer.

Albertsen P.

Eur Urol. 2010 Dec;58(6):836-7. doi: 10.1016/j.eururo.2010.09.003. Epub 2010 Sep 15. No abstract available.

PMID:
20851512
10.

Expectant management of prostate cancer.

Griffin AS, O'Rourke ME.

Semin Oncol Nurs. 2001 May;17(2):101-7. Review.

PMID:
11383241
11.

Tumour grade, treatment, and relative survival in a population-based cohort of men with potentially curable prostate cancer.

Ladjevardi S, Sandblom G, Berglund A, Varenhorst E.

Eur Urol. 2010 Apr;57(4):631-8. doi: 10.1016/j.eururo.2009.03.007. Epub 2009 Mar 10.

PMID:
19299069
12.

Clinical presentation and initial management of black men and white men with prostate cancer in the United Kingdom: the PROCESS cohort study.

Evans S, Metcalfe C, Patel B, Ibrahim F, Anson K, Chinegwundoh F, Corbishley C, Gillatt D, Kirby R, Muir G, Nargund V, Popert R, Wilson P, Persad R, Ben-Shlomo Y.

Br J Cancer. 2010 Jan 19;102(2):249-54. doi: 10.1038/sj.bjc.6605461. Epub 2009 Nov 24.

13.

Longitudinal quality of life in low-income men in a state-funded prostate cancer treatment program.

Zavala MW, Maliski SL, Kwan L, Miller DC, Fink A, Litwin MS.

J Health Care Poor Underserved. 2008 Feb;19(1):200-14. doi: 10.1353/hpu.2008.0026.

PMID:
18263996
14.

Race/ethnicity and the intensity of medical monitoring under 'watchful waiting' for prostate cancer.

Shavers VL, Brown M, Klabunde CN, Potosky AL, Davis W, Moul J, Fahey A.

Med Care. 2004 Mar;42(3):239-50.

PMID:
15076823
15.

Active surveillance program for prostate cancer: an update of the Johns Hopkins experience.

Tosoian JJ, Trock BJ, Landis P, Feng Z, Epstein JI, Partin AW, Walsh PC, Carter HB.

J Clin Oncol. 2011 Jun 1;29(16):2185-90. doi: 10.1200/JCO.2010.32.8112. Epub 2011 Apr 4.

16.

Time trends and characteristics of men choosing watchful waiting for initial treatment of localized prostate cancer: results from CaPSURE.

Harlan SR, Cooperberg MR, Elkin E, Lubeck DP, Meng M, Mehta SS, Carroll PR.

J Urol. 2003 Nov;170(5):1804-7.

PMID:
14532780
17.

Editorial comment on: tumour grade, treatment, and relative survival in a population-based cohort of men with potentially curable prostate cancer.

Gallina A.

Eur Urol. 2010 Apr;57(4):639. doi: 10.1016/j.eururo.2009.03.008. Epub 2009 Mar 10. No abstract available.

PMID:
19299073
18.

Editorial comment on: tumor grade, treatment, and relative survival in a population-based cohort of men with potentially curable prostate cancer.

Yossepowitch O.

Eur Urol. 2010 Apr;57(4):639-40. doi: 10.1016/j.eururo.2009.03.009. Epub 2009 Mar 10. No abstract available.

PMID:
19299071
19.
20.
Items per page

Supplemental Content

Write to the Help Desk